Dactylospongia elegans-A Promising Drug Source: Metabolites, Bioactivities, Biosynthesis, Synthesis, and Structural-Activity Relationship

Mar Drugs. 2022 Mar 23;20(4):221. doi: 10.3390/md20040221.

Abstract

Marine environment has been identified as a huge reservoir of novel biometabolites that are beneficial for medical treatments, as well as improving human health and well-being. Sponges have been highlighted as one of the most interesting phyla as new metabolites producers. Dactylospongia elegans Thiele (Thorectidae) is a wealth pool of various classes of sesquiterpenes, including hydroquinones, quinones, and tetronic acid derivatives. These metabolites possessed a wide array of potent bioactivities such as antitumor, cytotoxicity, antibacterial, and anti-inflammatory. In the current work, the reported metabolites from D. elegans have been reviewed, including their bioactivities, biosynthesis, and synthesis, as well as the structural-activity relationship studies. Reviewing the reported studies revealed that these metabolites could contribute to new drug discovery, however, further mechanistic and in vivo studies of these metabolites are needed.

Keywords: Dactylospongia elegans; bioactivities; biosynthesis; sesquiterpenes; sponges; synthesis.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Humans
  • Hydroquinones
  • Porifera*
  • Quinones / pharmacology
  • Sesquiterpenes* / pharmacology

Substances

  • Anti-Bacterial Agents
  • Hydroquinones
  • Quinones
  • Sesquiterpenes